GE HealthCare Declares $0.035 Q1 2026 Cash Dividend Payable May 15
The Board of Directors declared a cash dividend of $0.035 per share for Q1 2026, payable May 15 to shareholders of record April 3. GE HealthCare, a $20.6 billion global medical technology and diagnostics company, provides imaging, AI-enabled solutions and pharmaceutical diagnostics across multiple care segments.
1. Dividend Declaration Details
The Board of Directors approved a quarterly cash dividend of $0.035 per share for the first quarter of 2026, scheduled for payment on May 15 to shareholders of record as of April 3, 2026. This continues the company’s practice of distributing earnings to shareholders on a regular basis.
2. Shareholder Impact and Yield Considerations
The announced dividend underscores GE HealthCare’s commitment to returning capital and provides a steady income stream for investors. Relative to peers in the medical technology sector, the payout reflects a conservative cash deployment strategy and supports income-focused investment theses.
3. Company Profile and Financial Scope
GE HealthCare is a $20.6 billion global healthcare technology provider employing approximately 54,000 people. The company operates across Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics segments, leveraging AI, cloud and software offerings to address complex clinical challenges.